Matthew Fomonyuy Yuyun, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Resynchronization Therapy | 3 | 2023 | 525 | 1.250 |
Why?
|
Adrenomedullin | 2 | 2017 | 87 | 1.080 |
Why?
|
Albuminuria | 6 | 2005 | 692 | 1.070 |
Why?
|
Arrhythmias, Cardiac | 6 | 2023 | 2265 | 0.920 |
Why?
|
Bradycardia | 3 | 2020 | 305 | 0.850 |
Why?
|
Heart Failure | 7 | 2023 | 10793 | 0.740 |
Why?
|
Atrioventricular Block | 2 | 2018 | 120 | 0.700 |
Why?
|
Defibrillators, Implantable | 4 | 2021 | 1441 | 0.690 |
Why?
|
Death, Sudden, Cardiac | 3 | 2022 | 1542 | 0.650 |
Why?
|
Sick Sinus Syndrome | 1 | 2018 | 44 | 0.630 |
Why?
|
Tetrahydrofolates | 1 | 2018 | 61 | 0.620 |
Why?
|
Electric Countershock | 1 | 2021 | 533 | 0.610 |
Why?
|
Device Removal | 1 | 2021 | 648 | 0.530 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5003 | 0.480 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1408 | 0.470 |
Why?
|
Primary Dysautonomias | 2 | 2022 | 25 | 0.440 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15070 | 0.420 |
Why?
|
Nitric Oxide | 1 | 2018 | 2121 | 0.340 |
Why?
|
Africa South of the Sahara | 3 | 2020 | 727 | 0.330 |
Why?
|
Hemodynamics | 1 | 2018 | 4197 | 0.310 |
Why?
|
Myocardial Infarction | 4 | 2017 | 11668 | 0.300 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2022 | 11699 | 0.280 |
Why?
|
Retinal Diseases | 2 | 2022 | 687 | 0.270 |
Why?
|
Catheter Ablation | 2 | 2023 | 2737 | 0.270 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4454 | 0.260 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2020 | 847 | 0.260 |
Why?
|
Hypoglycemia | 2 | 2022 | 855 | 0.260 |
Why?
|
Stroke Volume | 3 | 2022 | 4941 | 0.250 |
Why?
|
Morbidity | 2 | 2020 | 1763 | 0.240 |
Why?
|
Genital Diseases, Male | 1 | 2004 | 81 | 0.230 |
Why?
|
Diabetic Neuropathies | 1 | 2003 | 410 | 0.170 |
Why?
|
Incidence | 7 | 2022 | 20913 | 0.170 |
Why?
|
Risk Factors | 15 | 2022 | 71974 | 0.170 |
Why?
|
Cardiology | 2 | 2020 | 1654 | 0.170 |
Why?
|
Ventricular Function, Left | 2 | 2021 | 3620 | 0.160 |
Why?
|
Urinary Tract Infections | 1 | 2004 | 766 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2022 | 451 | 0.150 |
Why?
|
Education | 1 | 2020 | 543 | 0.150 |
Why?
|
Developed Countries | 1 | 2020 | 433 | 0.150 |
Why?
|
Humans | 37 | 2023 | 739398 | 0.140 |
Why?
|
Minority Groups | 2 | 2020 | 1197 | 0.140 |
Why?
|
Heart Rate | 3 | 2022 | 4095 | 0.130 |
Why?
|
Atrial Flutter | 1 | 2018 | 265 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2018 | 691 | 0.130 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 981 | 0.130 |
Why?
|
Treatment Outcome | 5 | 2023 | 62693 | 0.120 |
Why?
|
Homocysteine | 1 | 2018 | 647 | 0.120 |
Why?
|
Middle Aged | 21 | 2022 | 212863 | 0.120 |
Why?
|
Aged | 14 | 2023 | 162698 | 0.120 |
Why?
|
Survival Rate | 3 | 2020 | 12761 | 0.120 |
Why?
|
Action Potentials | 1 | 2021 | 1813 | 0.110 |
Why?
|
Cause of Death | 1 | 2004 | 3564 | 0.110 |
Why?
|
Male | 22 | 2023 | 349022 | 0.110 |
Why?
|
Autonomic Nervous System | 3 | 2022 | 670 | 0.110 |
Why?
|
Electric Power Supplies | 1 | 2013 | 99 | 0.110 |
Why?
|
Stroke | 3 | 2022 | 9898 | 0.110 |
Why?
|
Electrocardiography | 4 | 2022 | 6426 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1165 | 0.110 |
Why?
|
Pacemaker, Artificial | 1 | 2018 | 813 | 0.110 |
Why?
|
Lyme Disease | 1 | 2018 | 612 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15036 | 0.100 |
Why?
|
Folic Acid | 1 | 2018 | 1297 | 0.100 |
Why?
|
Income | 1 | 2020 | 1877 | 0.100 |
Why?
|
England | 3 | 2014 | 522 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6516 | 0.090 |
Why?
|
Prognosis | 5 | 2017 | 28901 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12328 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1483 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12237 | 0.090 |
Why?
|
Prospective Studies | 6 | 2023 | 53037 | 0.090 |
Why?
|
Female | 21 | 2022 | 378853 | 0.090 |
Why?
|
Veterans | 1 | 2023 | 2505 | 0.090 |
Why?
|
Heart Diseases | 1 | 2022 | 2782 | 0.090 |
Why?
|
Coronary Disease | 1 | 2004 | 6068 | 0.080 |
Why?
|
Age Distribution | 2 | 2004 | 2904 | 0.080 |
Why?
|
Time Factors | 3 | 2018 | 40050 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3087 | 0.070 |
Why?
|
Adult | 16 | 2022 | 213394 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1776 | 0.070 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2014 | 967 | 0.070 |
Why?
|
Hydrocortisone | 1 | 2014 | 1809 | 0.070 |
Why?
|
Blood Pressure | 1 | 2021 | 8554 | 0.070 |
Why?
|
Risk Assessment | 4 | 2021 | 23294 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2018 | 3279 | 0.060 |
Why?
|
Heart | 3 | 2022 | 4466 | 0.060 |
Why?
|
Cameroon | 1 | 2004 | 70 | 0.060 |
Why?
|
Urethral Stricture | 1 | 2004 | 49 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8039 | 0.060 |
Why?
|
Heart Arrest | 1 | 2014 | 1458 | 0.060 |
Why?
|
Prevalence | 3 | 2004 | 15153 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6416 | 0.050 |
Why?
|
Morocco | 1 | 2020 | 28 | 0.050 |
Why?
|
Africa, Northern | 1 | 2020 | 82 | 0.050 |
Why?
|
Ultrasonography | 1 | 2013 | 5941 | 0.050 |
Why?
|
Electrophysiology | 1 | 2023 | 1309 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2004 | 522 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2296 | 0.040 |
Why?
|
Africa | 1 | 2020 | 666 | 0.040 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 246 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 40389 | 0.040 |
Why?
|
Renal Insufficiency | 1 | 2004 | 803 | 0.040 |
Why?
|
Capacity Building | 1 | 2020 | 246 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2005 | 1356 | 0.040 |
Why?
|
Recurrence | 2 | 2023 | 8307 | 0.040 |
Why?
|
Ceftriaxone | 1 | 2018 | 167 | 0.040 |
Why?
|
Temperature | 1 | 2023 | 2202 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2023 | 76631 | 0.040 |
Why?
|
Doxycycline | 1 | 2018 | 327 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17384 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 57650 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 16764 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2004 | 1357 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23355 | 0.030 |
Why?
|
South Africa | 1 | 2020 | 1743 | 0.030 |
Why?
|
Hypertension | 2 | 2005 | 8431 | 0.030 |
Why?
|
Wales | 1 | 2014 | 85 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 38942 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2004 | 6871 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2006 | 5462 | 0.030 |
Why?
|
Mass Screening | 2 | 2006 | 5265 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 466 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1409 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3909 | 0.030 |
Why?
|
Developing Countries | 1 | 2004 | 2779 | 0.030 |
Why?
|
Odds Ratio | 1 | 2004 | 9846 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2014 | 539 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15194 | 0.020 |
Why?
|
Animals | 1 | 2022 | 168368 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 2861 | 0.020 |
Why?
|
Exercise Test | 1 | 2018 | 2069 | 0.020 |
Why?
|
Sex Factors | 1 | 2004 | 10398 | 0.020 |
Why?
|
Logistic Models | 1 | 2004 | 13402 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5742 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3510 | 0.020 |
Why?
|
Smoking | 1 | 2004 | 8960 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18349 | 0.020 |
Why?
|
Patient Admission | 1 | 2014 | 1383 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5098 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4582 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4205 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 24714 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12948 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 10999 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10247 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2006 | 1279 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2014 | 5305 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 14740 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3106 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7136 | 0.010 |
Why?
|
Area Under Curve | 1 | 2004 | 1655 | 0.010 |
Why?
|
ROC Curve | 1 | 2004 | 3526 | 0.010 |
Why?
|
Adolescent | 1 | 2004 | 85405 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 21507 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2006 | 3609 | 0.010 |
Why?
|
Health Surveys | 1 | 2004 | 4022 | 0.010 |
Why?
|
Blood Glucose | 1 | 2004 | 6237 | 0.010 |
Why?
|